CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: GENOMICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Consumables And Reagent
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Instruments, Systems And Software
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Sequencing
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. PCR
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Flow Cytometry
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Microarray
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: GENOMICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Functional Genomics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Epigenomics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Pathway Analysis
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Biomarker Discovery
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: GENOMICS MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Clinical Research
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Academic And Government Institutions
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Hospitals And Clinics
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Pharmaceutical And Biotechnology Companies
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
7.6. Others
7.6.1. Key Market Trends, Growth Factors and Opportunities
7.6.2. Market Size and Forecast, By Region
7.6.3. Market Share Analysis, By Country
CHAPTER 8: GENOMICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Genomics Market
8.2.7.1. Market Size and Forecast, By Product
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Genomics Market
8.2.8.1. Market Size and Forecast, By Product
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Genomics Market
8.2.9.1. Market Size and Forecast, By Product
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Genomics Market
8.3.7.1. Market Size and Forecast, By Product
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Genomics Market
8.3.8.1. Market Size and Forecast, By Product
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Genomics Market
8.3.9.1. Market Size and Forecast, By Product
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Genomics Market
8.3.10.1. Market Size and Forecast, By Product
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Genomics Market
8.3.11.1. Market Size and Forecast, By Product
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest Of Europe Genomics Market
8.3.12.1. Market Size and Forecast, By Product
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Genomics Market
8.4.7.1. Market Size and Forecast, By Product
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Genomics Market
8.4.8.1. Market Size and Forecast, By Product
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Genomics Market
8.4.9.1. Market Size and Forecast, By Product
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Genomics Market
8.4.10.1. Market Size and Forecast, By Product
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Genomics Market
8.4.11.1. Market Size and Forecast, By Product
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Genomics Market
8.4.12.1. Market Size and Forecast, By Product
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Genomics Market
8.5.7.1. Market Size and Forecast, By Product
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Genomics Market
8.5.8.1. Market Size and Forecast, By Product
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Genomics Market
8.5.9.1. Market Size and Forecast, By Product
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. UAE Genomics Market
8.5.10.1. Market Size and Forecast, By Product
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
8.5.11. Rest of LAMEA Genomics Market
8.5.11.1. Market Size and Forecast, By Product
8.5.11.2. Market Size and Forecast, By Technology
8.5.11.3. Market Size and Forecast, By Application
8.5.11.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping Of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Color Genomics, Inc.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. BGI Genomics
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Danaher Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Eppendorf AG
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Eurofins Scientific SE
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. F. Hoffmann-La Roche Ltd.
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. GE Healthcare
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Illumina, Inc.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Bio-Rad Laboratories, Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. GENOMICS MARKET FOR CONSUMABLES AND REAGENT, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. GENOMICS MARKET FOR SERVICES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. GENOMICS MARKET FOR INSTRUMENTS, SYSTEMS AND SOFTWARE, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. GLOBAL GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 6. GENOMICS MARKET FOR SEQUENCING, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. GENOMICS MARKET FOR PCR, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. GENOMICS MARKET FOR FLOW CYTOMETRY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GENOMICS MARKET FOR MICROARRAY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 10. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. GLOBAL GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 12. GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 15. GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 16. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 17. GLOBAL GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 18. GENOMICS MARKET FOR CLINICAL RESEARCH, BY REGION, 2024 - 2033 ($BILLION)
TABLE 19. GENOMICS MARKET FOR ACADEMIC AND GOVERNMENT INSTITUTIONS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 20. GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 21. GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2024 - 2033 ($BILLION)
TABLE 22. GENOMICS MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 23. GENOMICS MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 24. NORTH AMERICA GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 25. NORTH AMERICA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 26. NORTH AMERICA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 27. NORTH AMERICA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 28. NORTH AMERICA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 29. U.S. GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 30. U.S. GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 31. U.S. GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 32. U.S. GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 33. CANADA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 34. CANADA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 35. CANADA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 36. CANADA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 37. MEXICO GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 38. MEXICO GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 39. MEXICO GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 40. MEXICO GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. EUROPE GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 42. EUROPE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 43. EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 44. EUROPE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 45. EUROPE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 46. FRANCE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 47. FRANCE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 48. FRANCE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 49. FRANCE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 50. GERMANY GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 51. GERMANY GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 52. GERMANY GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 53. GERMANY GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 54. ITALY GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 55. ITALY GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 56. ITALY GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. ITALY GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. SPAIN GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 59. SPAIN GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 60. SPAIN GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 61. SPAIN GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. UK GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 63. UK GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 64. UK GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 65. UK GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 66. REST OF EUROPE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 67. REST OF EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 68. REST OF EUROPE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 69. REST OF EUROPE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 70. ASIA-PACIFIC GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 71. ASIA-PACIFIC GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 72. ASIA-PACIFIC GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 73. ASIA-PACIFIC GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 74. ASIA-PACIFIC GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 75. CHINA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 76. CHINA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 77. CHINA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 78. CHINA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 79. JAPAN GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 80. JAPAN GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 81. JAPAN GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 82. JAPAN GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 83. INDIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 84. INDIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 85. INDIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 86. INDIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 87. SOUTH KOREA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 88. SOUTH KOREA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 89. SOUTH KOREA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 90. SOUTH KOREA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 91. AUSTRALIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 92. AUSTRALIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 93. AUSTRALIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 94. AUSTRALIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 95. REST OF ASIA-PACIFIC GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 96. REST OF ASIA-PACIFIC GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 97. REST OF ASIA-PACIFIC GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 98. REST OF ASIA-PACIFIC GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 99. LAMEA GENOMICS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 100. LAMEA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 101. LAMEA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 102. LAMEA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 103. LAMEA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 104. BRAZIL GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 105. BRAZIL GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 106. BRAZIL GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 107. BRAZIL GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 108. SOUTH AFRICA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 109. SOUTH AFRICA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 110. SOUTH AFRICA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 111. SOUTH AFRICA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 112. SAUDI ARABIA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 113. SAUDI ARABIA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 114. SAUDI ARABIA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 115. SAUDI ARABIA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 116. UAE GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 117. UAE GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 118. UAE GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 119. UAE GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 120. REST OF LAMEA GENOMICS MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 121. REST OF LAMEA GENOMICS MARKET, BY TECHNOLOGY, 2024 - 2033 ($BILLION)
TABLE 122. REST OF LAMEA GENOMICS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 123. REST OF LAMEA GENOMICS MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 124. COLOR GENOMICS, INC.: KEY EXECUTIVES
TABLE 125. COLOR GENOMICS, INC.: COMPANY SNAPSHOT
TABLE 126. COLOR GENOMICS, INC.: OPERATING SEGMENTS
TABLE 127. COLOR GENOMICS, INC.: PRODUCT PORTFOLIO
TABLE 128. COLOR GENOMICS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129. BGI GENOMICS: KEY EXECUTIVES
TABLE 130. BGI GENOMICS: COMPANY SNAPSHOT
TABLE 131. BGI GENOMICS: OPERATING SEGMENTS
TABLE 132. BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 133. BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134. AGILENT TECHNOLOGIES: KEY EXECUTIVES
TABLE 135. AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 136. AGILENT TECHNOLOGIES: OPERATING SEGMENTS
TABLE 137. AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 138. AGILENT TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139. DANAHER CORPORATION: KEY EXECUTIVES
TABLE 140. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 141. DANAHER CORPORATION: OPERATING SEGMENTS
TABLE 142. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 143. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144. EPPENDORF AG: KEY EXECUTIVES
TABLE 145. EPPENDORF AG: COMPANY SNAPSHOT
TABLE 146. EPPENDORF AG: OPERATING SEGMENTS
TABLE 147. EPPENDORF AG: PRODUCT PORTFOLIO
TABLE 148. EPPENDORF AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 149. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
TABLE 150. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
TABLE 151. EUROFINS SCIENTIFIC SE: OPERATING SEGMENTS
TABLE 152. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
TABLE 153. EUROFINS SCIENTIFIC SE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
TABLE 155. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
TABLE 156. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
TABLE 157. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
TABLE 158. F. HOFFMANN-LA ROCHE LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 159. GE HEALTHCARE: KEY EXECUTIVES
TABLE 160. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 161. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 162. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 163. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 164. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 165. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 166. ILLUMINA, INC.: OPERATING SEGMENTS
TABLE 167. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 168. ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 169. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
TABLE 170. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
TABLE 171. BIO-RAD LABORATORIES, INC. : OPERATING SEGMENTS
TABLE 172. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
TABLE 173. BIO-RAD LABORATORIES, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL GENOMICS MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF GENOMICS MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN GENOMICS MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALGENOMICS MARKET
FIGURE 10. GLOBAL GENOMICS MARKET SEGMENTATION, BY PRODUCT
FIGURE 11. GENOMICS MARKET FOR CONSUMABLES AND REAGENT, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. GENOMICS MARKET FOR INSTRUMENTS, SYSTEMS AND SOFTWARE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. GLOBAL GENOMICS MARKET SEGMENTATION, BY TECHNOLOGY
FIGURE 15. GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. GENOMICS MARKET FOR PCR, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. GENOMICS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 19. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. GLOBAL GENOMICS MARKET SEGMENTATION, BY APPLICATION
FIGURE 21. GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 23. GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 24. GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 25. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 26. GLOBAL GENOMICS MARKET SEGMENTATION, BY END USER
FIGURE 27. GENOMICS MARKET FOR CLINICAL RESEARCH, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 28. GENOMICS MARKET FOR ACADEMIC AND GOVERNMENT INSTITUTIONS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 29. GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 30. GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 31. GENOMICS MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 32. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 33. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 34. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 35. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 36. COMPETITIVE DASHBOARD
FIGURE 37. COMPETITIVE HEATMAP: GENOMICS MARKET
FIGURE 38. TOP PLAYER POSITIONING, 2023
FIGURE 39. COLOR GENOMICS, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. COLOR GENOMICS, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. COLOR GENOMICS, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. BGI GENOMICS: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. BGI GENOMICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. BGI GENOMICS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. AGILENT TECHNOLOGIES: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. AGILENT TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. AGILENT TECHNOLOGIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. EPPENDORF AG: NET SALES, 2021-2023 ($BILLION)
FIGURE 52. EPPENDORF AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. EPPENDORF AG: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. EUROFINS SCIENTIFIC SE: NET SALES, 2021-2023 ($BILLION)
FIGURE 55. EUROFINS SCIENTIFIC SE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. EUROFINS SCIENTIFIC SE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 60. GE HEALTHCARE: NET SALES, 2021-2023 ($BILLION)
FIGURE 61. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 62. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 63. ILLUMINA, INC.: NET SALES, 2021-2023 ($BILLION)
FIGURE 64. ILLUMINA, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 65. ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 66. BIO-RAD LABORATORIES, INC. : NET SALES, 2021-2023 ($BILLION)
FIGURE 67. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 68. BIO-RAD LABORATORIES, INC. : REVENUE SHARE, BY REGION, 2023 (%)
